Alnylam Pharmaceuticals
ALNY
#618
Rank
ยฃ24.45 B
Marketcap
ยฃ188.92
Share price
3.69%
Change (1 day)
64.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company